We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOSYSTEMS

Biosystems researches, develops, produces and markets a wide range of instruments and reagents for clinical chemistry... read more Featured Products: More products

Download Mobile App





BioSystems Highlights New iFOB Integral System at MedLab 2019

By LabMedica International staff writers
Posted on 31 Jan 2019
BioSystems S.A. More...
(Barcelona, Spain) presented its analytical systems at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. MedLab Middle East 2019 attracted more than 19,610 unique visitors and the exhibition floor area housed 678+ exhibitors dedicated to sharing the most recent technology available in the IVD, and medical laboratory market. The MedLab Congress also enjoyed massive growth, welcoming more than 6,000 delegates to the multi-track conferences this year.

At MedLab Middle East 2019, BioSystems presented its new Fecal Occult Blood (iFOB) integral system, which provides a diagnostic solution for FOB testing. Colorectal cancer (CRC) is the third-most common cancer and the fourth-leading cause of cancer-related deaths in the world. CRC is treatable and preventable if it is detected in the early stages, with the detection of fecal occult blood being the key to preventing colorectal cancer.

BioSystems’ new iFOB system is comprised of an easy-to-use stool collection tube for easy sampling at the patient’s home or in the laboratory, an improved immunoturbidimetric assay in the form of a new and high sensitive antibody against human hemoglobin (no cross reaction with non-human Hb), an updated version of the company’s A15 analyzer with a new cap piercing function (no need to decap or recap samples tube after testing), and a dedicated software for fecal samples.

The iFOB system provides an accurate, reliable and safe method for FOB testing, making this test accessible to any kind of laboratory. In addition to FOB tests, BioSystems’ integral system can be updated with new fecal tests such as fecal Calprotectin, Transferrin and Helicobacter pylori, making the system a complete solution for stool samples analysis in the laboratory.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.